Our Hamburg-based German antitrust team has contributed a chapter on Germany to Lexology Get The Deal Through’s global report on Pharmaceutical Antitrust. In their contribution, they provide guidance on the regulatory framework, merger control aspects and potential enforcement risks with regard to anticompetitive agreements as well as anticompetitive unilateral conduct for those active in the German pharmaceutical sector.